The Cytogenetic Market is estimated at $ 1,111 million in 2017 and is expected to reach $ 399 million in 2025, with an average annual growth rate of 13.5% from 2018 to 2025.

Cytogenetics is a field of biology that links cytology and genetics. Correlation is used to study the chromosomes and genes of cells and tissues. This work is done in relation to the number of chromosomes used in gene mutation and mutation and in the selection of the correct treatment for the detection of genetic diseases and the treatment of these genetic disorders. Cytogenetics includes a variety of techniques including comparative genomic hybridization, fluorescence in situ hybridization, karyotyping, and immunohistochemistry. These techniques require the use of cytogenetic agents such as test kits, media and reagents. Probe; Expendables; instrument; and software and services. These products and technologies are used in the screening of genetic diseases and in the design of personal medicine.

Along with the proliferation of chronic diseases, an increase in the prevalence of cancer and hereditary diseases, an increase in the global elderly population, and a surge in awareness of the worldwide acceptance of customized medicines are leading factors in the growth of the global cytogenetics market. But the high cost of advanced cytogenetics equipment is expected to hamper market growth. Conversely, the transition from fish to array-based technology is expected to provide many opportunities during the forecast period.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2116


The utilization rate of testing kits, media, and reagents is high, as they are the essential elements of every cytogenetic technique performed. However, the software & services segment is expected to grow at a high CAGR during the forecast period.

The key players of this market include
• Abbott Laboratories
• Agilent Technologies Inc.
• Applied Spectral Imaging Inc.
• Empire Genomics LLC.
• Illumina Inc.
• Irvine Scientific.
• OPKO Health Inc. (GeneDx.)
• PerkinElmer Inc.
• Sysmex Corporation (Oxford Gene Technology)
• Thermo Fisher Scientific Inc.

Other players (these players are not profiled in the report and the same can be included on request) in the value chain include Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., and MetaSystems.

Get Discount UP To 25% * Offer Till 31st Dec 2018@ https://www.alliedmarketresearch.com/checkout/570017

The comparative genomic hybridization segment is the largest segment in the global cytogenetics market, and is anticipated to grow at a high CAGR during the forecast period. The clinical & research laboratories segment is expected to grow at a moderate CAGR in the near future. On the other hand, the pharmaceutical & biotechnology companies segment is anticipated to record a high CAGR during the forecast period.

Key findings of the Cytogenetics Market:
• The testing kits, media, and reagents segment accounted for approximately three-fourths share of the global cytogenetics consumables market in 2017.
• The comparative genomic hybridization segment is expected to grow at a CAGR of 10.5% from 2018 to 2025.
• North America accounted for the majority of the share of the global market revenue in 2017.
• Asia-Pacific is expected to provide lucrative market growth opportunities, registering a CAGR of 12.1% from 2018 to 2025.
North America was the leading revenue contributor to the global cytogenetics market in 2017, and is expected to dominate the market during the forecast period. This is attributed to the presence of majority of major key players in this region. However, Asia-Pacific is expected to grow at the highest CAGR during the forecast period, owing to increase in affordability, surge in healthcare expenditure, and rise in awareness towards early screening of genetic disorders.

Access Full Summery @ https://www.alliedmarketresearch.com/cytogenetics-market